GPs' perspectives on GLP-1RAs for obesity management: a qualitative study in England.
Keating S. et al, (2025), Br J Gen Pract
The societal implications of using glucagon-like peptide-1 receptor agonists for the treatment of obesity
Scragg J. et al, (2025), Med
Effect of Weight Loss Interventions on the Symptomatic Burden and Biomarkers of Polycystic Ovary Syndrome A Systematic Review of Randomized Controlled Trials
Scragg J. et al, (2024), Annals of Internal Medicine, 177, 1664 - 1674
Dietary Approaches to the Management Of type 2 Diabetes (DIAMOND) in primary care: A protocol for a cluster randomised trial
Scragg J. et al, (2023), Contemporary Clinical Trials, 129
Physical Activity, Inactivity and Sleep in Patients with Significant Non-Alcoholic Fatty Liver Disease.
Scragg J. et al, (2022), Am J Med Sci, 363, 80 - 83